Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Digestive Diseases and Sciences|October 3, 2014
Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel diseaseSara Horst, Andrew Chao, Michael Rosen, et al.
Inflammatory Bowel Diseases|May 23, 2009
Durability of infliximab in Crohn's disease: a single-center experienceJason E Gonzaga, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|October 13, 2007
Receipt of preventive health services by IBD patients is significantly lower than by primary care patientsLisbeth Selby, Sunanda Kane, John Wilson, et al.
Digestive Diseases and Sciences|July 16, 2021
Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor α Antagonists in an Elderly IBD Population: A Single Institution Retrospective ExperienceBaldeep S Pabla, C Alex Wiles, James C Slaughter, et al.
Inflammatory Bowel Diseases|July 29, 2009
Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?Ashwin N Ananthakrishnan, Dawn B Beaulieu, Alex Ulitsky, et al.
Inflammatory Bowel Diseases|December 13, 2024
Gender and Sex Differences in Abdominal Pain, Fatigue, And Psychological Symptoms Among Adults with Inflammatory Bowel Disease: A Network AnalysisKendra Kamp, Pei-Lin Yang, Chi-Shan Tsai, et al.
Clinical Pharmacokinetics|February 5, 2021
Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel DiseaseWan Sun, Blair Fennimore, Dawn B Beaulieu, et al.
Digestive Diseases and Sciences|June 25, 2026
Patient Perspectives of Intestinal Ultrasound in IBD: A Quantitative Evaluation of Satisfaction and Diagnostic PreferenceKacie H Denton, James C Slaughter, Audrey Bennett, et al.
The American Journal of Gastroenterology|September 28, 2004
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's diseaseWilliam J Sandborn, Stephen Hanauer, Edward V Loftus, et al.
Crohn'S & Colitis 360|February 13, 2023
Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel DiseaseC Alex Wiles, Nisha B Shah, Jake Bell, et al.
Pageof 16